Clinical presentation, diagnosis, classification and management of peritoneal mesothelioma: a review
- 1 October 2017
- journal article
- review article
- Published by AME Publishing Company in Journal of Gastrointestinal Oncology
- Vol. 8 (5) , 915-924
Abstract
Peritoneal mesothelioma (PM) is an uncommon but a serious, and often, fatal primary peritoneal tumour, with increasing incidence worldwide. Conventional systemic chemotherapy, generally based on experience with pleural mesothelioma, usually has disappointing results considering PM as a terminal condition. Patients usually present with non-specific symptoms of abdominal distension and pain making the diagnosis challenging. As PM is confined to the abdomen for all, or much, of its clinical course, a multimodality treatment combining cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has emerged as a new standard of care, and has been reported to achieve promising survival outcomes and local disease control in selected patients with PM. This review updates the presentation, diagnosis, classification and treatment strategies for PM.Keywords
This publication has 68 references indexed in Scilit:
- Métastases révélatrices de mésothéliomes malins du péritoine : difficultés diagnostiques à propos de deux cas et conduite à tenirAnnales de Pathologie, 2016
- Clinical impacts of mesothelin expression in gastrointestinal carcinomasWorld Journal of Gastrointestinal Pathophysiology, 2016
- Malignant Peritoneal Mesothelioma: Prognostic Factors and Oncologic Outcome AnalysisAnnals of Surgical Oncology, 2013
- The Role of Perioperative Systemic Chemotherapy in Diffuse Malignant Peritoneal Mesothelioma Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyAnnals of Surgical Oncology, 2013
- Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy, and Role of Laparoscopy in Diagnosis, Staging, and TreatmentSurgical Oncology Clinics of North America, 2012
- 18F-FDG PET/CT in a Recurrent Diffuse Malignant Peritoneal MesotheliomaClinical Nuclear Medicine, 2012
- Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancerEuropean Journal of Surgical Oncology, 2008
- Advances in the systemic therapy of malignant pleural mesotheliomaNature Clinical Practice Oncology, 2008
- Analysis of Factors Associated With Outcome in Patients With Malignant Peritoneal Mesothelioma Undergoing Surgical Debulking and Intraperitoneal ChemotherapyJournal of Clinical Oncology, 2003
- The epidemiology of mesothelioma in historical contextEuropean Respiratory Journal, 1996